Page last updated: 2024-09-05

anidulafungin and P carinii Pneumonia

anidulafungin has been researched along with P carinii Pneumonia in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Ashbaugh, A; Cushion, MT; Hauser, PM; Mosley, C; Sayson, SG1
Adeojo, LW; Alfaro, R; Ashbaugh, A; Cushion, MT; Kovacs, JA; Kumar, P; Lu, R; Mannino, R; Tramont, E1
Ashbaugh, A; Cushion, MT; Hendrix, K; Linke, MJ; Porollo, A; Sayson, SG; Tisdale, N1
Damiani, C; Le Gal, S; Nevez, G; Totet, A1
Chang, HC; Chen, TC; Yang, WT1
Ashbaugh, A; Collins, MS; Cushion, MT; Linke, MJ; Lynch, K1
Bartlett, MS; Boylan, CJ; Current, WL; Goheen, MP; Lee, CH; Queener, SF; Shaw, MM; Smith, JW1

Other Studies

7 other study(ies) available for anidulafungin and P carinii Pneumonia

ArticleYear
Anidulafungin Treatment Blocks the Sexual Cycle of Pneumocystis murina and Prevents Growth and Survival without Rescue by an Alternative Mode of Replication.
    Microbiology spectrum, 2022, 12-21, Volume: 10, Issue:6

    Topics: Anidulafungin; Animals; Echinocandins; Ecosystem; Pneumocystis; Pneumonia, Pneumocystis

2022
A Novel Encochleated Formulation Improves Atovaquone Activity in a Murine Model of Pneumocystis Pneumonia.
    The Journal of infectious diseases, 2021, 07-15, Volume: 224, Issue:2

    Topics: Anidulafungin; Animals; Antifungal Agents; Atovaquone; Disease Models, Animal; Mice; Pneumonia, Pneumocystis

2021
Gene Expression of Pneumocystis murina after Treatment with Anidulafungin Results in Strong Signals for Sexual Reproduction, Cell Wall Integrity, and Cell Cycle Arrest, Indicating a Requirement for Ascus Formation for Proliferation.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:5

    Topics: Anidulafungin; Animals; Antifungal Agents; Cell Cycle Checkpoints; Cell Proliferation; Cell Wall; Male; Mice; Pneumocystis; Pneumonia, Pneumocystis

2018
The Fascinating Echinocandin-Treated Mouse Model of Pneumocystis murina To Understand Pneumocystis jirovecii.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:8

    Topics: Anidulafungin; Animals; Cell Cycle Checkpoints; Cell Proliferation; Cell Wall; Echinocandins; Mice; Pneumocystis; Pneumocystis carinii; Pneumonia, Pneumocystis

2018
Pneumocystis jirovecii pneumonia in a human immunodeficiency virus-infected patient with G6PD deficiency-successful treatment with anidulafungin.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:24

    Topics: AIDS-Related Opportunistic Infections; Anidulafungin; Antifungal Agents; Antiretroviral Therapy, Highly Active; Glucosephosphate Dehydrogenase Deficiency; HIV Infections; Humans; Immunocompromised Host; Male; Pneumonia, Pneumocystis; Treatment Outcome; Young Adult

2018
Characterization of a distinct host response profile to Pneumocystis murina asci during clearance of pneumocystis pneumonia.
    Infection and immunity, 2013, Volume: 81, Issue:3

    Topics: Albumins; Anidulafungin; Animals; Antifungal Agents; Bronchoalveolar Lavage Fluid; Cell Wall; Echinocandins; Female; Flow Cytometry; Inflammation; Lung; Mice; Mice, Inbred C3H; Pneumocystis; Pneumonia, Pneumocystis

2013
Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:8

    Topics: Anidulafungin; Animals; Antifungal Agents; Cell Line; Cell Wall; Dexamethasone; Echinocandins; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microscopy, Electron; Peptides, Cyclic; Pneumocystis; Pneumonia, Pneumocystis; Rats

1996